The immune system is an intricate network of specialized cells and molecular messengers. Perfected by evolution, the immune system is arguably very good at keeping us alive and well… for the most part. Cancer is one exception.
The American Society of Clinical Oncology (ASCO) has released a Position Statement titled “Strategies for Reducing Cancer Health Disparities among Sexual and Gender Minority (SGM) Populations.” It was written by ASCO’s Health Disparities Committee, which was first created to tackle inequities in racial and ethnic minorities. Over the years, this committee has expanded its mission to address inequities in cancer care wherever they exist.
This week, Lancet Public Health published a study on the 2003 global tobacco control treaty’s impact on the adoption of tobacco reduction measures around the world, which has led to a 2.5% reduction in global smoking rates. The treaty obligates the 180 countries committed to it to implement strong evidence-based policies. While the U.S. signed on in 2004, it has never ratified this treaty.
We soundly oppose President Trump's budget outline, which would cut $6 billion from the National Institutes of Health (NIH). Reducing NIH's funding by nearly 20 percent will devastate our nation's already fragile federal research infrastructure and undercut a longstanding commitment to biomedical science that has fueled advances in cancer prevention, diagnosis, and treatment.
Experts estimate that at least one-third of all adult cancer cases are linked to lifestyle choices and habits, which include diet. While numerous studies have looked at food and cancer, it’s challenging to come away with definitive conclusions. Here are five commonly debated truths when it comes to food and cancer.
Many people associate surgery – removal of a tumor – as a critical step in a curative course of cancer treatment. Once the tumor is removed, following a course of radiation treatment, many also assume that what comes next is chemotherapy.
Recent advances in understanding the biology of lymphomas are helping spur new treatment approaches for patients. Cancer.Net Associate Editor in Lymphoma Dr. Michael E. Williams, chief of the Hematology/Oncology Division and director of the Hematologic Malignancies Program at the University of Virginia Cancer Center summarizes recent findings.
Lung cancer takes more than 1.5 million lives worldwide each year. This translates to 4,100 deaths per day, on average, nearly three a minute. Even in the modern era of targeted therapy, prospects of long-term survival remain elusive.
Pediatric oncology has long been on the leading edge of research, innovation and personalized approaches to care.
The Journal of the American Medical Association (JAMA), published “Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014” by Modak et al. The study found that cancer deaths in the U.S. declined by 20 percent from 1980-2014, but there were large differences in cancer mortality as well as areas with unusually higher mortality rates across counties. ASCO's Presdient Daniel F. Hayes, MD, FACP, FASCO,weighs in on what this means for the cancer community.
Cancer and its treatment can profoundly diminish a person’s physical condition and quality of life. The good news is that exercise can help alleviate a whole range of symptoms and improve overall well-being. Perhaps contrary to common belief, exercise is safe for majority of patients and survivors
The World Health Organization and the National Cancer Institute recently released a report that finds smoking and its side effects cost the world's economies more than $1 trillion and kill about 6 million people each year. The report also noted that this number is expected to rise by more than a third by 2030. ASCO issued the following statement from President Daniel F. Hayes, MD, FASCO, FACP.
Small renal masses are defined as solid kidney tumors < 4 cm. They are often discovered unintentionally, when a patient undergoes an imaging test, such as ultrasound, for another reason. Up to 25% of small renal masses are benign tumors and another 25% are malignant but slow-growing (indolent).
We hear about many factors that contribute to breast cancer risk – genetics, lifestyle, hormones are just a few are consistently discussed and researched. However, it’s difficult to point to one single cause when it comes to breast cancer risk. By considering all known factors, researchers are creating powerful tools to predict a woman’s risk for breast cancer more accurately.
The American Cancer Society issued a report today that finds a 25% drop in the overall cancer death rate in the United States since 1991. ASCO issued the following statement from Chief Medical Officer Richard L. Schilsky, MD, FASCO, FACP.